Legislative Activity

The Cosmetic Supply Chain Transparency Act of 2025 enhances cosmetic regulation by requiring detailed ingredient and supply chain information sharing between brand owners and suppliers. This law mandates the FDA to create a public list of harmful, nonfunctional chemical traces that suppliers must eventually test for and certify. Importantly, this federal legislation preserves the right of states to enact stricter ingredient or transparency rules than those established here.

This resolution declares a health and safety emergency disproportionately affecting children due to prior administration directives that promoted fossil fuels and suppressed climate science. Congress asserts that these actions harm children's fundamental rights to life and a stable environment by worsening climate change impacts. The bill demands the current administration cease policies that increase greenhouse gases and restore access to suppressed climate research. Ultimately, it calls for aligning all energy and climate laws with the duty to protect the rights and future of young people.

The Uterine Cancer Study Act of 2025 mandates a comprehensive federal study to investigate the potential link between the use of chemical hair straighteners and the risk of developing uterine cancer. This research must specifically examine disparities in cancer rates among women of color. The study will ultimately recommend whether the FDA should require additional safety testing for these hair products.

The Uterine Fibroid Intervention and Gynecological Health Treatment Act of 2025 aims to improve the detection and treatment of uterine fibroids. It mandates federal research to develop evidence-based early detection strategies and establishes grant programs for states to fund screening, education, and intervention services, prioritizing vulnerable populations. Furthermore, the bill allocates funding for research into pain management related to fibroid surgery and other uterine conditions.

This bill, titled the Epstein Files Transparency Act, mandates the Attorney General to release nearly all unclassified Department of Justice records related to Jeffrey Epstein within 30 days of enactment. The legislation strictly limits the justifications for withholding or redacting documents, prohibiting secrecy based on political sensitivity or potential embarrassment. The only permissible redactions involve victim privacy, child sexual abuse material, or narrowly defined threats to active investigations or national security classifications. Upon completion, the Attorney General must submit a detailed report to Congress listing all released and withheld materials, including an unredacted list of all named government officials.

The Stephanie Tubbs Jones Uterine Fibroid Research and Education Act of 2025 aims to significantly increase federal research, public education, and provider awareness regarding uterine fibroids. The bill mandates expanded research coordination across federal agencies and authorizes funding to study the condition, which disproportionately affects minority women. It also requires the creation of public awareness campaigns detailing non-hysterectomy treatment options and mandates data collection on Medicaid/CHIP spending for fibroid treatments.

The Safeguarding Transit Operations to Prohibit China Act (STOP China Act) bans the use of federal transit funds to purchase or maintain transit vehicles and related infrastructure connected to specified foreign entities, primarily those linked to China. This prohibition targets "covered vehicles" supplied by "covered entities" to prevent national security risks and unfair trade practices. The law mandates the creation of a public watchlist identifying these restricted entities to ensure compliance.

The Pharmacy Benefit Manager Reform Act of 2025 aims to increase transparency and accountability across the prescription drug supply chain. It mandates fairer pharmacy network access for Medicare beneficiaries and imposes strict new financial reporting and service fee requirements on Pharmacy Benefit Managers (PBMs) working with Medicare and private health plans. Furthermore, the bill establishes new federal mechanisms to accurately track drug acquisition costs in Medicaid and explicitly bans the practice of "spread pricing" in state Medicaid contracts.

This resolution expresses support for designating July 10th as Journeyman Lineworkers Recognition Day. It honors the essential and dangerous work performed by these skilled professionals, especially their heroic efforts in restoring power after major disasters. The day serves to recognize their service and remember those who have lost their lives performing this vital work.

The Food Chemical Reassessment Act of 2025 mandates that the FDA systematically review the safety of at least ten existing food ingredients every three years, starting in 2026. This process targets substances like certain food additives, colorings, and GRAS ingredients, prioritizing those with the greatest public health concern. If a reassessment determines a substance is unsafe, the FDA is required to take regulatory action, such as repealing approvals or revoking authorizations. The Act also establishes an advisory committee to guide the FDA on reassessment standards and methods.

The FAIR Bet Act amends tax law to allow taxpayers to deduct wagering losses dollar-for-dollar against their wagering winnings, up to 100% of those winnings. This change modifies the previous limitation on deducting gambling losses. Essentially, it ensures that gambling losses can fully offset gambling income for tax purposes.

This bill officially renames the Department of Veterans Affairs community-based outpatient clinic in San Jose, California, to honor Corporal Patrick D. Tillman. The renaming recognizes Tillman's heroic service and ultimate sacrifice after leaving his NFL career to join the U.S. Army following the September 11th attacks. This legislation ensures the San Jose VA Clinic will forever bear the name of the San Jose native and national hero.

The GLOBE Act of 2025 establishes a comprehensive U.S. strategy to champion and protect the human rights of LGBTQI people globally through diplomacy, targeted sanctions, and foreign assistance reforms. The bill mandates enhanced reporting on violence and discrimination while creating new interagency roles and funds to support international advocacy and development efforts. Furthermore, it reforms immigration law to better protect LGBTQI asylum seekers and ensures inclusive implementation of U.S. global health programs like PEPFAR.

The AMMO Act modernizes federal oversight of ammunition by requiring federal licenses for all ammunition dealers and mandating background checks through NICS for transfers by licensed sellers to non-licensees. The bill also prohibits straw purchases of ammunition and establishes new federal limits on bulk ammunition sales, requiring recordkeeping and reporting for these transactions. These provisions will take effect 120 days after the date of enactment.

The No Secret Police Act of 2025 mandates that federal officers engaged in border security or immigration enforcement must clearly display identification, wear visible badges or uniforms, and refrain from wearing face coverings during detentions or arrests. This ensures accountability by requiring clear identification from Department of Homeland Security (DHS) personnel. The bill also requires the Secretary of Homeland Security to report on current tactical gear policies and research methods to improve officer visibility.

This resolution formally recognizes the history, achievements, and ongoing struggles of the LGBTQIA+ community in the United States. It serves as a declaration by Congress affirming that LGBTQIA+ rights are human rights and encouraging the celebration of Pride Month. The bill highlights key historical milestones, legal victories, and acknowledges the persistent challenges and violence faced by the community. Ultimately, it commits the U.S. to continuing the pursuit of full equality for all citizens.

This resolution formally recognizes the constitutional right to peaceful protest while strongly condemning violence and illegal acts committed during demonstrations. It criticizes the federal government's deployment of military forces during recent events, arguing the actions were an overreach that bypassed proper legal and state authority. Ultimately, the bill asserts the importance of transparency in law enforcement and denounces rhetoric that escalates community tensions.

The Ensuring Women’s Right to Reproductive Freedom Act prohibits states from interfering with or retaliating against individuals who provide or receive abortion services that are legal in the state where the service occurs. This protection extends to interstate travel for legal abortion care and the movement of FDA-approved abortion-related drugs across state lines. Individuals harmed by violations can sue in federal court for damages and legal fees.

The Women’s Health Protection Act of 2025 establishes a federal statutory right to access abortion services, prohibiting medically unnecessary restrictions that impede care before fetal viability. This Act protects the right of patients to travel across state lines to receive reproductive healthcare and allows providers to offer services free from state interference that conflicts with established medical standards. It preempts conflicting state and local laws and provides robust enforcement mechanisms for individuals and the Attorney General to challenge violations.

The End Junk Fees for Renters Act aims to protect tenants by banning application and screening fees for federally assisted rental units. It also caps late rent fees at 3% and mandates that landlords disclose key rental history and maintenance information before a lease is signed. Furthermore, the bill directs federal agencies to define "junk fees" and prohibits landlords from reporting unpaid junk fees to credit bureaus.